On the 18th of December webcast starting at 7 minutes Silvio and Marcello Santoro both indicated that talks with medical reimbersers were at an advanced stage at both a Federal level and State level plus ongoing discussions with the FDA should enable existing stocks with appropriate new and complying labels to be rolled out and administered to patients within the coming weeks….Yes I agree that the process is prone to not running smoothly but we are now 46 days down the path with existing stock that was inventoried for EAP
https://webcast.openbriefing.com/msb-ann-2024/player/index.php?player_id=55726
Ann: Ryoncil Commercial Launch Update and Product Pipeline, page-171
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
0.005(0.30%) |
Mkt cap ! $2.114B | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.65 | $5.992M | 3.610M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31682 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 102 | 1 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |